CasNo.129453-61-8,Fulvestrant,(129453-61-8) Suppliers

0 Metric Ton	Negotiable

Min.Order :0 Metric Ton
Purity: more than 97%
Payment Terms : L/C,T/T

Keywords

Fulvestrant Fulvestrant Fulvestrant

Quick Details

Appearance:white powder
Application:Fulvestrant (trade name Faslodex, by AstraZeneca) is a drug treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen the
PackAge:
ProductionCapacity:|Metric Ton|Day
Storage:
Transportation:

Superiority:

Fulvestrant is a drug treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. It is a complete estrogen receptor antagonist with no agonist effects, which in addition, accelerates the proteasomal degradation of the estrogen receptor. The drug has poor oral bioavailability, and is administered monthly via intramuscular injection.

Details:

Fulvestrant is a drug treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. It is a complete estrogen receptor antagonist with no agonist effects, which in addition, accelerates the proteasomal degradation of the estrogen receptor. The drug has poor oral bioavailability, and is administered monthly via intramuscular injection.

USP grade.